Privium Fund Management’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,900
Closed -$6K 237
2022
Q3
$6K Hold
73,900
﹤0.01% 162
2022
Q2
$7K Hold
73,900
﹤0.01% 183
2022
Q1
$25K Hold
73,900
0.01% 187
2021
Q4
$41K Buy
+73,900
New +$42.1K 0.01% 153

Other funds holding EQHA.WS

Privium Fund Management's EQHA.WS Position: Q4 2022 in Review

Privium Fund Management sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 73,900 shares — an estimated $6K sold.

Privium Fund Management first reported a position in EQHA.WS in Q4 2021 and held it in 4 quarters. The position peaked at $41K in Q4 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Privium Fund Management reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Privium Fund Management sold 73,900 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $6K.
  • Privium Fund Management first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 4 quarters.
  • Privium Fund Management's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $41K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Privium Fund Management's 13F filing for Q4 2022, filed 3 Feb 2023.